Latest Asx Company Filings News

Alligator Energy has completed commissioning of its Samphire pilot plant and is set to begin a four-month uranium field recovery trial, signalling a key step towards project development.

Whitefield Income Limited reported a robust half-year profit surge and a significant capital raise, maintaining steady dividends amid a cautiously optimistic economic outlook.

Clever Culture Systems posted a $1.32 million loss for the half year ending December 2025, reflecting a strategic shift and reduced government grants. Despite this, the company strengthened its cash position, repaid government debt, and grew its APAS Independence instrument footprint globally.

Hydralyte USA has implemented targeted headcount reductions saving around US$25,000 monthly and completed manufacturing runs to resolve supply shortages, replenishing inventory with key distributors to support near-term sales growth.

Kinatico Ltd reports robust H1 FY26 results, driven by a 49.5% surge in SaaS revenue and the launch of its AI-powered Kinatico Compliance platform, significantly broadening its addressable market.

GR Engineering Services has been named preferred contractor for Brightstar Resources’ Laverton Processing Plant, a major 1.5 Mtpa gold facility in Western Australia, pending final investment and funding decisions.

Renegade Exploration has reported significant gold, silver, and copper rock chip assay results from its Fireball Ridge Project in Nevada, confirming the potential of multiple mineralised zones within the prolific Walker Lane Trend.

Centrepoint Alliance reports a 17% rise in normalised EBITDA for H1 FY26 and announces a strategic divestment of its lending aggregation business to Astute Financial Management, expected to boost annual EBITDA by $0.4 million from FY27.

Aumake Limited has secured a four-year exclusive global distribution agreement with EZZ Life Sciences, targeting $10 million in sales and expanding its footprint in high-margin nutraceuticals.

Lincoln Minerals is sharpening its focus on copper exploration with a renewed push at its Minbrie Project and new collaborations targeting base metals and graphite markets.

Acrow Limited reaffirms its first half FY26 revenue guidance with a 22% increase year-on-year, driven by robust demand in key Australian regions and strategic capital investments.

Rhythm Biosciences has inked a non-exclusive distribution agreement with 4Cyte Pathology to integrate its ColoSTAT® colorectal cancer blood test into a vast pathology network across eastern Australia, aiming to boost adoption and accessibility.